 Eiger BioPharmaceuticals, Inc. NASDAQ:EIGR Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Sarah Mathieson - Senior Vice President-Corporate Affairs David Cory - President Chief Executive Officer Ingrid Choong - Senior Vice President-Clinical Development Eldon Mayer - Chief Commercial Officer Sri Ryali - Chief Financial Officer Colleen Craig - Vice President-Metabolic Diseases Conference Call Participants Ashik Mubarack - Citi Bert Hazlett - BTIG Luke Herrmann - Baird Michael Higgins - Ladenburg Thalmann Operator Good day, ladies and gentlemen, and welcome to the Eiger BioPharmaceuticals First Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. 